Park Place Capital Corp Acquires 1,411 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Park Place Capital Corp increased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 32.0% during the first quarter, according to its most recent filing with the SEC. The fund owned 5,824 shares of the healthcare conglomerate's stock after buying an additional 1,411 shares during the quarter. UnitedHealth Group accounts for approximately 0.8% of Park Place Capital Corp's portfolio, making the stock its 26th largest holding. Park Place Capital Corp's holdings in UnitedHealth Group were worth $3,050,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in UNH. Brighton Jones LLC raised its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its stake in UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. Bank Pictet & Cie Europe AG boosted its position in UnitedHealth Group by 3.9% during the fourth quarter. Bank Pictet & Cie Europe AG now owns 263,655 shares of the healthcare conglomerate's stock worth $133,373,000 after purchasing an additional 9,872 shares during the period. Whipplewood Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $625,000. Finally, Heritage Investors Management Corp boosted its holdings in UnitedHealth Group by 1.9% in the 4th quarter. Heritage Investors Management Corp now owns 68,313 shares of the healthcare conglomerate's stock worth $34,557,000 after buying an additional 1,262 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on UNH shares. UBS Group cut their price target on UnitedHealth Group from $400.00 to $385.00 and set a "buy" rating for the company in a report on Wednesday. Robert W. Baird lowered UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 target price for the company. in a report on Wednesday, June 11th. Hsbc Global Res lowered shares of UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a research report on Wednesday, May 21st. Piper Sandler decreased their target price on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a report on Tuesday, June 3rd. Finally, Barclays reduced their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research report on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $415.57.

UnitedHealth Group Trading Up 2.1%

Shares of UnitedHealth Group stock traded up $6.23 during trading on Friday, reaching $308.85. The company's stock had a trading volume of 13,584,804 shares, compared to its average volume of 7,448,051. The company has a market cap of $280.17 billion, a price-to-earnings ratio of 12.93, a PEG ratio of 1.43 and a beta of 0.44. The firm's 50-day moving average is $339.15 and its two-hundred day moving average is $456.28. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the business posted $6.91 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a yield of 2.86%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex acquired 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer now owns 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 in the last quarter. Insiders own 0.28% of the company's stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.